Procurement comparison · Updated 2026-06-28
Dermagraft vs. Kindr
Dermagraft (cellular dermal substitute) · Organogenesis · Q4106
Kindr Health's amniotic allograft line is offered in both ambient-stable lyophilized and cryopreserved formats with multi-source supply continuity. The comparison below focuses strictly on supply chain, storage, and billing attributes — not clinical efficacy.
Supply chain & storage
- Storage
- Dermagraft: –75 °C cryopreservation required. Kindr lyophilized amniotic: ambient.
- Shelf life
- Dermagraft: ~6 months from manufacture at –75 °C. Kindr lyophilized: 3–5 years ambient.
- Cold chain risk
- Dermagraft's short shelf life amplifies waste exposure when ordering exceeds 30-day consumption. Procurement requires JIT ordering discipline.
- Sizes
- Dermagraft: single fixed size (~37.5 cm² piece). Kindr: multiple sheet sizes available.
Billing & reimbursement
- Q-code
- Dermagraft: Q4106.
- Payment basis
- ASP+6% in physician office; OPPS APC packaged in HOPD.
- LCD notes
- Covered under DFU LCDs in most MAC jurisdictions following 4-week conservative care.
Procurement takeaway
Dermagraft is operationally heavy: ultra-low storage plus 6-month shelf life. Sites without dedicated DFU volume to absorb the order-to-application window typically standardize on ambient-stable alternatives for waste control.
Run side-by-side TCO →Other comparisons
Comparison data drawn from publicly available manufacturer IFUs, product labels, and CMS HCPCS files as of 2026-06-28. Trademarks belong to their respective owners. No clinical superiority is claimed or implied. Verify all data against current manufacturer documentation before procurement decisions.